These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12574143)

  • 1. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system.
    Bezzina CR; Rook MB; Groenewegen WA; Herfst LJ; van der Wal AC; Lam J; Jongsma HJ; Wilde AA; Mannens MM
    Circ Res; 2003 Feb; 92(2):159-68. PubMed ID: 12574143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.
    Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F
    PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill.
    Groenewegen WA; Firouzi M; Bezzina CR; Vliex S; van Langen IM; Sandkuijl L; Smits JP; Hulsbeek M; Rook MB; Jongsma HJ; Wilde AA
    Circ Res; 2003 Jan; 92(1):14-22. PubMed ID: 12522116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype.
    Gosselin-Badaroudine P; Keller DI; Huang H; Pouliot V; Chatelier A; Osswald S; Brink M; Chahine M
    PLoS One; 2012; 7(5):e38331. PubMed ID: 22675453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect.
    Niu DM; Hwang B; Hwang HW; Wang NH; Wu JY; Lee PC; Chien JC; Shieh RC; Chen YT
    J Med Genet; 2006 Oct; 43(10):817-21. PubMed ID: 16707561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia.
    Tan BH; Iturralde-Torres P; Medeiros-Domingo A; Nava S; Tester DJ; Valdivia CR; Tusié-Luna T; Ackerman MJ; Makielski JC
    Cardiovasc Res; 2007 Dec; 76(3):409-17. PubMed ID: 17897635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.
    Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H
    Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique mixed phenotype and unexpected functional effect revealed by novel compound heterozygosity mutations involving SCN5A.
    Medeiros-Domingo A; Tan BH; Iturralde-Torres P; Tester DJ; Tusié-Luna T; Makielski JC; Ackerman MJ
    Heart Rhythm; 2009 Aug; 6(8):1170-5. PubMed ID: 19632629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiogram changes and atrial arrhythmias in individuals carrying sodium channel SCN5A D1275N mutation.
    Vanninen SUM; Nikus K; Aalto-Setälä K
    Ann Med; 2017 Sep; 49(6):496-503. PubMed ID: 28294644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.
    McNair WP; Sinagra G; Taylor MR; Di Lenarda A; Ferguson DA; Salcedo EE; Slavov D; Zhu X; Caldwell JH; Mestroni L;
    J Am Coll Cardiol; 2011 May; 57(21):2160-8. PubMed ID: 21596231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
    Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
    Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implications of genetic mutations in the sodium channel gene (SCN5A).
    Moric E; Herbert E; Trusz-Gluza M; Filipecki A; Mazurek U; Wilczok T
    Europace; 2003 Oct; 5(4):325-34. PubMed ID: 14753626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia.
    McNair WP; Ku L; Taylor MR; Fain PR; Dao D; Wolfel E; Mestroni L;
    Circulation; 2004 Oct; 110(15):2163-7. PubMed ID: 15466643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sodium-channel mutation causes isolated cardiac conduction disease.
    Tan HL; Bink-Boelkens MT; Bezzina CR; Viswanathan PC; Beaufort-Krol GC; van Tintelen PJ; van den Berg MP; Wilde AA; Balser JR
    Nature; 2001 Feb; 409(6823):1043-7. PubMed ID: 11234013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel.
    Zhang Y; Wang T; Ma A; Zhou X; Gui J; Wan H; Shi R; Huang C; Grace AA; Huang CL; Trump D; Zhang H; Zimmer T; Lei M
    Acta Physiol (Oxf); 2008 Dec; 194(4):311-23. PubMed ID: 18616619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.
    Viswanathan PC; Benson DW; Balser JR
    J Clin Invest; 2003 Feb; 111(3):341-6. PubMed ID: 12569159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.